We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+3.36%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$4.51B
AUM Growth
+$737M
Cap. Flow
+$736M
Cap. Flow %
16.32%
Top 10 Hldgs %
19.25%
Holding
501
New
284
Increased
70
Reduced
66
Closed
74

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$99.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$80.7M
3
JNJ icon
Johnson & Johnson
JNJ
+$77.7M
4
EA icon
Electronic Arts
EA
+$61.9M
5
DHR icon
Danaher
DHR
+$60.2M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$99.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.8M
3
MDT icon
Medtronic
MDT
+$68.7M
4
NXPI icon
NXP Semiconductors
NXPI
+$61.6M
5
LITE icon
Lumentum
LITE
+$58.9M

Sector Composition

Rank Sector Weight
1 Healthcare 47.83%
2 Technology 26.25%
3 Communication Services 6.68%
4 Consumer Discretionary 4.05%
5 Financials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLMIU
276
DELISTED
Plum Acquisition Corp. I Units
PLMIU
$2.24M 0.05%
+225,000
New +$2.23M
TWNT.U
277
DELISTED
Tailwind Two Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of
TWNT.U
$2.22M 0.05%
+225,000
New +$2.25M
MIT.U
278
DELISTED
Mason Industrial Technology, Inc. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant to purchase one share of Class A common stock
MIT.U
$2.19M 0.05%
+220,000
New +$2.23M
LITS
279
Lite Strategy Inc
LITS
$32.5M
$2.19M 0.05%
+31,867
New +$2.23M
DNZ.U
280
DELISTED
D and Z Media Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Warrant
DNZ.U
$2.17M 0.05%
+218,990
New +$2.23M
VERO
281
DELISTED
Venus Concept
VERO
$2.11M 0.05%
5,431
+1,189
+28% +$474K
ONTF
282
DELISTED
ON24
ONTF
$2.07M 0.05%
+42,720
New +$2.49M
PRDS
283
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$2.07M 0.05%
+207,674
New +$2.15M
LABP
284
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$2.05M 0.05%
+21,334
New +$2.78M
CCCC icon
285
C4 Therapeutics
CCCC
$400M
$2.04M 0.05%
55,024
-111,299
-67% -$4.43M
HUGS.U
286
DELISTED
USHG Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-third of one Warrant
HUGS.U
$2.01M 0.04%
+199,628
New +$2.03M
ACQRU
287
DELISTED
Independence Holdings Corp. Units
ACQRU
$2M 0.04%
+200,000
New +$2.01M
FRSGU
288
DELISTED
First Reserve Sustainable Growth Corp. Unit
FRSGU
$2M 0.04%
+200,000
New +$2M
LGACU
289
DELISTED
Lazard Growth Acquisition Corp. I Units
LGACU
$2M 0.04%
+200,000
New +$2.03M
TSIBU
290
DELISTED
Tishman Speyer Innovation Corp. II Unit
TSIBU
$2M 0.04%
+200,000
New +$2.06M
SBII.U
291
DELISTED
Sandbridge X2 Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
SBII.U
$2M 0.04%
+200,000
New +$1.99M
KRNLU
292
DELISTED
Kernel Group Holdings, Inc. Units
KRNLU
$2M 0.04%
+200,000
New +$2.03M
ROSS.U
293
DELISTED
Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
ROSS.U
$1.99M 0.04%
+200,000
New +$1.99M
GSEVU
294
DELISTED
Gores Holdings VII, Inc. Units
GSEVU
$1.99M 0.04%
+200,000
New +$2.04M
CHAA.U
295
DELISTED
Catcha Investment Corp Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
CHAA.U
$1.99M 0.04%
+200,000
New +$2.04M
LHAA
296
DELISTED
Lerer Hippeau Acquisition Corp. Class A Common Stock
LHAA
$1.98M 0.04%
+200,000
New +$1.99M
BGSX.U
297
DELISTED
Build Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
BGSX.U
$1.97M 0.04%
+200,000
New +$1.98M
RMGCU
298
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
$1.94M 0.04%
+194,889
New +$2.02M
FNCH
299
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$1.93M 0.04%
+3,978
New +$2.03M
KLAQ
300
DELISTED
KL Acquisition Corp Class A Common Stock
KLAQ
$1.83M 0.04%
+189,155
New +$1.85M
10 11
12
13 14

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Woodline Partners held 501 positions worth $4.51B, up 20% from $3.77B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Woodline Partners deployed $736M of net new capital in Q1 2021, opening 284 new positions and adding to 70 existing holdings. Its largest new stake was Gilead Sciences: 1,541,893 shares worth $99.7M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 43% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Amgen, an estimated $99.3M trimmed.

  • Woodline Partners's largest Q1 2021 buy was Gilead Sciences: 1,541,893 shares worth $99.7M.
  • Woodline Partners added most to Regeneron Pharmaceuticals in Q1 2021, an estimated $80.7M increase.
  • Woodline Partners's biggest Q1 2021 reduction was Amgen, cutting an estimated $99.3M.
  • Woodline Partners fully exited Alphabet (Google) Class A in Q1 2021, selling an estimated $97.8M.
  • Woodline Partners's ten largest holdings make up 19% of its $4.51B portfolio in Q1 2021.
  • Woodline Partners opened 284 new positions and closed 74 in Q1 2021.
  • Woodline Partners's portfolio value rose 20% quarter-over-quarter to $4.51B.

Based on Woodline Partners's 13F filing for Q1 2021, filed 17 May 2021.